RG
Redmile Group’s Ovid Therapeutics OVID Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-40,674
| Closed | -$137K | – | 75 |
|
|
2021
Q3 | $137K | Hold |
40,674
| – | – | ﹤0.01% | 75 |
|
|
2021
Q2 | $159K | Sell |
40,674
-81,276
| -67% | -$318K | ﹤0.01% | 86 |
|
|
2021
Q1 | $490K | Hold |
121,950
| – | – | 0.01% | 83 |
|
|
2020
Q4 | $282K | Hold |
121,950
| – | – | ﹤0.01% | 86 |
|
|
2020
Q3 | $700K | Hold |
121,950
| – | – | 0.01% | 79 |
|
|
2020
Q2 | $899K | Hold |
121,950
| – | – | 0.02% | 78 |
|
|
2020
Q1 | $363K | Hold |
121,950
| – | – | 0.01% | 67 |
|
|
2019
Q4 | $506K | Hold |
121,950
| – | – | 0.01% | 62 |
|
|
2019
Q3 | $395K | Sell |
121,950
-615,600
| -83% | -$1.99M | 0.01% | 61 |
|
|
2019
Q2 | $1.36M | Hold |
737,550
| – | – | 0.04% | 66 |
|
|
2019
Q1 | $1.31M | Hold |
737,550
| – | – | 0.04% | 68 |
|
|
2018
Q4 | $1.79M | Buy |
737,550
+7,400
| +1% | +$17.9K | 0.07% | 62 |
|
|
2018
Q3 | $4.14M | Buy |
730,150
+608,200
| +499% | +$3.45M | 0.13% | 64 |
|
|
2018
Q2 | $951K | Sell |
121,950
-38,768
| -24% | -$302K | 0.03% | 68 |
|
|
2018
Q1 | $1.14M | Sell |
160,718
-152,064
| -49% | -$1.07M | 0.04% | 58 |
|
|
2017
Q4 | $3.09M | Sell |
312,782
-138,400
| -31% | -$1.37M | 0.13% | 59 |
|
|
2017
Q3 | $3.77M | Buy |
451,182
+2,401
| +0.5% | +$20.1K | 0.19% | 54 |
|
|
2017
Q2 | $4.24M | Buy |
+448,781
| New | +$4.24M | 0.26% | 51 |
|